Aveo Pharmaceuticals, Inc.
AVEODelisted Jan 19, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001325879
Aveo Pharmaceuticals, Inc. was delisted on Jan 19, 2023; its insiders filed their last Form 4 on Jan 19, 2023; 110 institutions reported holding it in 13F filings for Q4 2022, worth $367.6M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Aveo Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 57 | 57 | 0 |
| Shares | 15.4M | 14.1M | −1.29M (−8.4%) |
| Value | $72.3M | $79.0M | +$6.65M (+9.2%) |
New holders (9)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 231,920 | $1.30M | 0.01% |
| Renaissance Technologies LLC | 49,600 | $277.0K | 0.00% |
| Jane Street Group, LLC | 13,228 | $74.0K | 0.00% |
| Dakota Wealth Management | 12,500 | $70.0K | 0.01% |
| Marshall Wace, LLP | 11,021 | $62.0K | 0.00% |
| PDT Partners, LLC | 10,866 | $61.0K | 0.01% |
| Barclays PLC | 6,021 | $34.0K | 0.00% |
| Citigroup Inc | 1,460 | $8.00K | 0.00% |
| Blue Bell Private Wealth Management, LLC | 20 | $0 | 0.00% |
Sold out (9)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 1,500,000 | $7.04M |
| Pura Vida Investments, LLC | 123,416 | $579.0K |
| Citadel Advisors LLC | 112,347 | $527.0K |
| Sender Co & Partners, Inc. | 92,026 | $432.0K |
| Jump Financial, LLC | 24,181 | $113.0K |
| XTX Topco Ltd | 18,128 | $85.0K |
| Shay Capital LLC | 13,243 | $62.0K |
| Edge Wealth Management LLC | 1,000 | $5.00K |
| Andrew Hill Investment Advisors, Inc. | 10 | $0 |